避孕药市场规模、份额和成长分析（按类型、通路和地区）：产业预测（2024-2031）

Contraceptive Drugs Market Size, Share, Growth Analysis, By Type (Oral Contraceptives, Combined Oral Contraceptive Pills), By Distribution (Hospital & Clinics, Retail Pharmacy), By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球避孕药具市场规模为195亿美元，从2023年的210.8亿美元成长到2031年的393.1亿美元，在预测期间（2024-2031年）预计复合年增长率为8.1%。

由于性行为感染病的流行率不断上升以及越来越多的女性无法获得这些选择，预计避孕药具和器具的市场将会成长。世界卫生组织 (WHO) 强调，2019 年有超过 11 亿育龄妇女需要计划生育，其中 2.7 亿人的需求未被满足。透过有针对性的计划和提高认识来解决意外怀孕的努力预计将推动市场扩张。相反，与避孕药具相关的副作用、对不孕率上升的担忧以及已开发国家不一致的性教育等挑战可能会阻碍经济成长。这些动态凸显了对创新解决方案的需求，以提高避孕市场的可近性和使用者满意度。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要企业采取的策略
近期市场趋势
主要企业市场占有率（2023年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

辉瑞公司（美国）
拜耳公司（德国）
梯瓦製药工业股份有限公司（以色列）
迈兰 NV（荷兰）
诺华公司（瑞士）
强生公司（美国）
GlaxoSmithKline plc (UK)
艾尔建公司（爱尔兰）
Agile Therapeutics, Inc.（美国）
皮拉马尔医疗保健（印度）
欧加农公司（荷兰）
HRA 药厂（法国）
CooperSurgical, Inc.（美国）
Church & Dwight Co., Inc.（美国）
默克公司（美国）
Famy Care 有限公司（印度）
国药集团股份有限公司 (中国)
太阳製药工业有限公司（印度）
Torrent 製药有限公司（印度）
雷迪博士实验室有限公司（印度）

结论和建议

简介目录

Product Code: SQMIG35I2122

Global Contraceptive Drugs Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.08 billion in 2023 to USD 39.31 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The market for contraceptive drugs and devices is poised for growth due to the rising incidence of sexually transmitted diseases and an increasing number of women lacking access to these options. As highlighted by the World Health Organization, in 2019, more than 1.1 billion women of reproductive age were in need of family planning, with 270 million experiencing unfulfilled demand. Efforts to address unplanned pregnancies through targeted programs and heightened awareness are expected to drive market expansion. Conversely, challenges such as side effects associated with contraceptives, concerns over growing infertility rates, and inconsistencies in sex education in developed nations may impede growth. These dynamics underscore the need for innovative solutions to enhance accessibility and user satisfaction in the contraceptive market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Drugs Market Segmental Analysis

Global Contraceptive Drugs Market is segmented by type, distribution and region. Based on type, the market is segmented into oral contraceptives, combined oral contraceptive pills, progestogen-only pills, topical contraceptives, contraceptive injectable and others. Based on distribution, the market is segmented into hospital & clinics, retail pharmacy, online pharmacy and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contraceptive Drugs Market

The Global Contraceptive Drugs market is significantly driven by the need to prevent unwanted pregnancies, particularly among poor and low-income populations where the incidence of unintended pregnancy remains high. A key factor behind this issue is the reliance on traditional contraception methods, which are often less effective. This situation is further compounded by the prevalence of unsafe abortions and associated maternal mortality rates. For instance, in Latin America, adolescents under 16 face a fourfold increase in the risk of maternal death compared to women in their thirties. Consequently, the adoption of contraceptive drugs plays a vital role in reducing the rates of unplanned pregnancies, thereby improving maternal health outcomes.

Restraints in the Global Contraceptive Drugs Market

The global contraceptive drugs market is facing significant constraints due to the adverse effects associated with birth control pills. Prolonged use, defined as ten years or more, can lead to various side effects including headaches, nausea, and abnormal bleeding. Additionally, medications that contain estrogen and progesterone have been linked to an elevated risk of developing blood clots, which can result in serious complications such as heart attacks. These potential health risks contribute to consumer hesitancy and reduce market demand, ultimately impeding the growth of the contraceptive drugs sector worldwide. Addressing these concerns is crucial for market expansion.

Market Trends of the Global Contraceptive Drugs Market

The Global Contraceptive Drugs market is experiencing a significant shift towards innovative technological advancements, particularly in the realm of digital contraception. This trend encompasses a growing emphasis on period tracking applications that empower users to monitor their menstrual cycles and assess pregnancy risk. A notable example is Berlin-based Clu's all-digital contraceptive, Clu Birth Control, which leverages comprehensive period data and predictive algorithms to enhance contraceptive efficiency. The ability for users to adjust their sexual behaviors based on personalized risk analytics positions digital contraception as a game-changer in reproductive health, reflecting a broader consumer demand for tailored, tech-driven contraceptive solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Contraceptive Drugs Market Size by Type & CAGR (2024-2031)

Market Overview
Oral Contraceptives
Combined Oral Contraceptive Pills
Progestogen-Only Pills
Topical Contraceptives
Contraceptive Injectable
Others

Global Contraceptive Drugs Market Size by Distribution & CAGR (2024-2031)

Market Overview
Hospital & Clinics
Retail Pharmacy
Online Pharmacy
Others

Global Contraceptive Drugs Market Size & CAGR (2024-2031)

North America (Type, Distribution)
- USA
- Canada
Europe (Type, Distribution)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Distribution)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Distribution)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Distribution)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agile Therapeutics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Healthcare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organon & Co. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HRA Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Church & Dwight Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Famy Care Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinopharm Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torrent Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments